MEI Pharma Inc (MEIP)
2.78
-0.03
(-1.07%)
USD |
NASDAQ |
Nov 22, 16:00
2.79
+0.01
(+0.36%)
After-Hours: 20:00
MEI Pharma Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 105.38M |
| June 30, 2023 | 48.82M |
| March 31, 2023 | 58.77M |
| December 31, 2022 | 62.57M |
| September 30, 2022 | 41.67M |
| June 30, 2022 | 40.70M |
| March 31, 2022 | 36.74M |
| December 31, 2021 | 35.15M |
| September 30, 2021 | 35.92M |
| June 30, 2021 | 34.80M |
| March 31, 2021 | 51.69M |
| December 31, 2020 | 44.82M |
| September 30, 2020 | 33.24M |
| June 30, 2020 | 27.76M |
| March 31, 2020 | 4.539M |
| December 31, 2019 | 4.544M |
| September 30, 2019 | 5.584M |
| June 30, 2019 | 4.915M |
| March 31, 2019 | 4.333M |
| December 31, 2018 | 3.517M |
| September 30, 2018 | 1.827M |
| June 30, 2018 | 1.622M |
| March 31, 2018 | 1.523M |
| December 31, 2017 | 5.595M |
| September 30, 2017 | 22.44M |
| Date | Value |
|---|---|
| June 30, 2017 | 23.25M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.539M
Minimum
Mar 2020
105.38M
Maximum
Sep 2023
41.69M
Average
38.72M
Median
Revenue (TTM) Benchmarks
| Avid Bioservices Inc | 142.36M |
| Evoke Pharma Inc | 8.617M |
| Revance Therapeutics Inc | 256.94M |
| NovaBay Pharmaceuticals Inc | 13.84M |
| Palatin Technologies Inc | -- |